Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

M6194

Sigma-Aldrich

Monoclonal Anti-Munc13/1 antibody produced in mouse

~2 mg/mL, clone Munc13-71, purified immunoglobulin, buffered aqueous solution

Sign Into View Organizational & Contract Pricing

MDL number:
UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

Munc13-71, monoclonal

form

buffered aqueous solution

species reactivity

rat, mouse

concentration

~2 mg/mL

technique(s)

microarray: suitable
western blot: 1-2 μg/mL using cytosolic rat brain S1 fraction

isotype

IgG2b

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

General description

Monoclonal Anti-Munc13-1 (mouse IgG2b isotype) is derived from the hybridoma Munc13-71 produced by the fusion of mouse myeloma cells (NS1 cells) and splenocytes from BALB/c mice immunized with a synthetic peptide of rat Munc13-1, conjugated to KLH. Protein unc-13 homolog A (Munc13-1) contains a diacylglycerol (DAG)/b phorbol ester-binding C1 domain. Munc13-1 are expression in axon is observed at various synapse populations.
Munc13/1 is a diacylglycerol receptor which is expressed in the presynaptic area.

Immunogen

synthetic peptide corresponding to amino acid 10-27 of rat munc13/1, conjugated to KLH.

Application

Monoclonal Anti-Munc13/1 antibody produced in mouse has been used in enzyme linked immunosorbent assay (ELISA) and immunoblotting.

Biochem/physiol Actions

Munc13/1 has a crucial role in synaptic vesicle priming. It interacts with Syntaxin 1A and helps it to bind to soluble NSF attachment protein receptor (SNARE) proteins. Thus it contributes to the stability of the SNARE complex. Deletion of Munc13/1 leads to complete arrest synaptic transmission.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Differential control of vesicle priming and short-term plasticity by Munc13 isoforms
Rosenmund C, et al.
Neuron, 33(3), 411-424 (2002)
ELKS/Voltage-dependent Ca2+ channel-beta subunit module regulates polarized Ca2+ influx in pancreatic beta cells
Ohara-Imaizumi M, et al.
Testing, 26(5), 1213-1226 (2019)
Edwin P Kwan et al.
Diabetes, 55(5), 1421-1429 (2006-04-29)
Munc13-1 is a diacylglycerol (DAG) receptor that is essential for synaptic vesicle priming. We recently showed that Munc13-1 is expressed in rodent and human islet beta-cells and that its levels are reduced in islets of type 2 diabetic humans and
Lijun Kang et al.
Cell metabolism, 3(6), 463-468 (2006-05-16)
Munc13-1 is a presynaptic protein that is essential for synaptic vesicle priming. Deletion of Munc13-1/unc13 causes total arrest of synaptic transmission due to a complete loss of fusion-competent synaptic vesicles. The requirement of Munc13-1 for large dense-core vesicles (LDCVs), however
Stefan Kalla et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 26(50), 13054-13066 (2006-12-15)
GFP (green fluorescent protein) fusion proteins have revolutionized research on protein dynamics at synapses. However, corresponding analyses usually involve protein expression methods that override endogenous regulatory mechanisms, and therefore cause overexpression and temporal or spatial misexpression of exogenous fusion proteins

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service